Distinct Ways of Retinoic Acid Receptors on Inhibition of AP-1 Activity in Gastric Cancer Cells

吴乔
DOI: https://doi.org/10.3969/j.issn.1007-7626.2001.04.005
2001-01-01
Abstract:Distinct ways between RARα (retinoic acid receptor α) and RARβ on inhibition of AP 1(activator protein 1) activity in gastric cancer cells and their relationship with ATRA (all trans retinoic acid) action were investigated.Transient transfection of RARβ expression vector into MKN 45 cells resulted in the significant and RARβ concentration dependent repression of AP 1 activity induced by TPA,regardless of the absence or presence of ATRA.In contrast,inhibition of TPA induced AP 1 activity by RARα required ATRA treatment and was also in an RARα concentration dependent manner.Furthermore,gel retardation assay was carried out and indicated that treatment of gastric cancer cells with TPA strongly enhanced AP 1 binding activity,whereas treatment with ATRA did not affect AP 1 binding in MKN 45 cells,which did not express RARβ but expressed RARα in a very low level.However,when BGC 823 cells,which expressed both RARα and RARβ in a high level,were treated with ATRA,TPA induced AP 1 binding activity was repressed obviously.In addition,the function domains of RARβ,which was responsible for anti AP 1 activity,were analyzed by different RARβ mutants.It was revealed that the deletion of DNA binding domain caused RARβ to be ineffective in the inhibition of AP 1 activity.However,ligand binding domain was not the necessary portion for the inhibition of AP 1 activity.These data strongly suggest that RARβ may be an inhibitor of AP 1 activity and RARα may be a target of ATRA action in gastric cancer cells,they function with ATRA in distinct ways,and then contribute to the growth inhibition of gastric cancer cells through anti AP 1 activity.
What problem does this paper attempt to address?